Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma

Mark Dawson; Stephen Opat; Yamna Taouk; Mark Donovan; Michele Zammit; Katherine Monaghan; Noemi Horvath; Andrew Roberts; Miles Prince; Mark Hertzberg; Catriona Ann McLean; Andrew Spencer

Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma

Mark Dawson, Stephen Opat, Yamna Taouk, Mark Donovan, Michele Zammit, Katherine Monaghan, Noemi Horvath, Andrew Roberts, Miles Prince, Mark Hertzberg, Catriona Ann McLean, Andrew Spencer

Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

29 Citations (Scopus)

Original language	English
Pages (from-to)	714 - 722
Number of pages	9
Journal	Clinical Cancer Research
Volume	15
Issue number	2
Publication status	Published - 2009

Cite this

@article{e16c48bcc32940ec8ca7740d02796f32,

title = "Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma",

author = "Mark Dawson and Stephen Opat and Yamna Taouk and Mark Donovan and Michele Zammit and Katherine Monaghan and Noemi Horvath and Andrew Roberts and Miles Prince and Mark Hertzberg and McLean, {Catriona Ann} and Andrew Spencer",

year = "2009",

language = "English",

volume = "15",

pages = "714 -- 722",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research (AACR)",

number = "2",

}

TY - JOUR

T1 - Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma

AU - Dawson, Mark

AU - Opat, Stephen

AU - Taouk, Yamna

AU - Donovan, Mark

AU - Zammit, Michele

AU - Monaghan, Katherine

AU - Horvath, Noemi

AU - Roberts, Andrew

AU - Prince, Miles

AU - Hertzberg, Mark

AU - McLean, Catriona Ann

AU - Spencer, Andrew

PY - 2009

Y1 - 2009

M3 - Article

SN - 1078-0432

VL - 15

SP - 714

EP - 722

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -